Literature DB >> 32563682

Artificial Stone Silicosis: Rapid Progression Following Exposure Cessation.

Antonio León-Jiménez1, Antonio Hidalgo-Molina2, Miguel Ángel Conde-Sánchez3, Aránzazu Pérez-Alonso4, José María Morales-Morales5, Eva María García-Gámez3, Juan Antonio Córdoba-Doña6.   

Abstract

BACKGROUND: Silicosis is rapidly emerging in high-income countries in relation to the replacement of natural stone with artificial stone, especially in the manufacturing and installation of kitchen and bathroom countertops. Progression of this form of silicosis following the cessation of exposure is unknown. RESEARCH QUESTION: The objective of this study was to determine the radiologic progression and lung function in individuals with artificial stone silicosis. STUDY DESIGN AND METHODS: Between 2009 and 2018, a total of 106 patients were diagnosed with artificial stone silicosis in the Bay of Cádiz area (southern Spain), 14.15% by using biopsy results and the remainder according to chest radiography and high-resolution CT imaging. Follow-up consisted of respiratory function tests and radiographic studies. All patients stopped working in the stone industry following diagnosis.
RESULTS: All patients were men; their mean ± SD age at diagnosis was 36.2 ± 7.0 years, and the mean duration of exposure was 12.0 ± 4.3 years. At diagnosis, 99 patients were considered to have simple silicosis (93.4%) and seven to have progressive massive fibrosis (PMF) (6.6%). After a mean follow-up of 4.01 ± 2.1 years, disease in 56% of patients had progressed two or more International Labour Office subcategories, and the number of patients with PMF had increased to 40 (37.7%). Regarding lung function, there was a decrease in FVC and FEV1, with an average decrease of 86.8 and 83.4 mL per year, respectively; in 25% of patients, the annual decrease was > 157 mL in FVC and > 133 mL in FEV1. Multivariable analysis showed that lower FVC at diagnosis and longer duration of exposure to silica were associated with progression to PMF.
INTERPRETATION: Artificial stone silicosis rapidly progresses to PMF even following exposure cessation, and a significant percentage of patients experience a very rapid decrease in lung function.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  artificial stone; lung function; occupational disease; silicosis

Mesh:

Year:  2020        PMID: 32563682     DOI: 10.1016/j.chest.2020.03.026

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients.

Authors:  Alejandro García-Núñez; Gema Jiménez-Gómez; Antonio Hidalgo-Molina; Juan Antonio Córdoba-Doña; Antonio León-Jiménez; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

2.  Transcriptomic and metabolomic profiling reveal the p53-dependent benzeneacetic acid attenuation of silica-induced epithelial-mesenchymal transition in human bronchial epithelial cells.

Authors:  Zhao Ju; Jianlin Shao; Meiling Zhou; Jing Jin; Huiji Pan; Ping Ding; Ruixue Huang
Journal:  Cell Biosci       Date:  2021-02-05       Impact factor: 7.133

3.  Investigation of MicroRNA and transcription factor mediated regulatory network for silicosis using systems biology approach.

Authors:  J K Choudhari; M K Verma; J Choubey; B P Sahariah
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

4.  Compositional and structural analysis of engineered stones and inorganic particles in silicotic nodules of exposed workers.

Authors:  Antonio León-Jiménez; José M Mánuel; Marcial García-Rojo; Marina G Pintado-Herrera; José Antonio López-López; Antonio Hidalgo-Molina; Rafael García; Pedro Muriel-Cueto; Nieves Maira-González; Daniel Del Castillo-Otero; Francisco M Morales
Journal:  Part Fibre Toxicol       Date:  2021-11-22       Impact factor: 9.400

5.  Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China.

Authors:  Hua Quan; Wenhong Wu; Guanghong Yang; Yunlin Wu; Wenlan Yang; Chunyan Min; Jinyun Shi; Lianhua Qin; Jin Huang; Jie Wang; Xiaochen Huang; Ling Mao; Yonghong Feng
Journal:  Front Med (Lausanne)       Date:  2022-04-04

Review 6.  Early Identification, Accurate Diagnosis, and Treatment of Silicosis.

Authors:  Tian Li; Xinyu Yang; Hong Xu; Heliang Liu
Journal:  Can Respir J       Date:  2022-04-25       Impact factor: 2.130

7.  Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019.

Authors:  Shimin Chen; Miao Liu; Fei Xie
Journal:  BMC Pulm Med       Date:  2022-06-21       Impact factor: 3.320

Review 8.  Current global perspectives on silicosis-Convergence of old and newly emergent hazards.

Authors:  Ryan F Hoy; Mohamed F Jeebhay; Catherine Cavalin; Weihong Chen; Robert A Cohen; Elizabeth Fireman; Leonard H T Go; Antonio León-Jiménez; Alfredo Menéndez-Navarro; Marcos Ribeiro; Paul-André Rosental
Journal:  Respirology       Date:  2022-03-18       Impact factor: 6.175

9.  What Do Safety Data Sheets for Artificial Stone Products Tell Us About Composition? A Comparative Analysis with Physicochemical Data.

Authors:  Chellan Kumarasamy; Dino Pisaniello; Sharyn Gaskin; Tony Hall
Journal:  Ann Work Expo Health       Date:  2022-08-07       Impact factor: 2.779

10.  Alveolar crystal burden in stone workers with artificial stone silicosis.

Authors:  Simon H Apte; Maxine E Tan; Viviana P Lutzky; Tharushi A De Silva; Andreas Fiene; Justin Hundloe; David Deller; Clair Sullivan; Peter T Bell; Daniel C Chambers
Journal:  Respirology       Date:  2022-02-17       Impact factor: 6.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.